Angle Plc ADR (OP: ANPCY )
All News about Angle Plc ADR
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
November 14, 2024
Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
November 14, 2024
Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients
November 10, 2024
Angle PLC Announces 100th Publication Supporting Parsortix System Use
September 25, 2024
Angle PLC Announces Half-year Report
September 25, 2024
Angle PLC Announces Exclusive agreement for DNA NGS panel
September 22, 2024
Angle PLC Announces Agreement with Recursion Pharmaceuticals
September 18, 2024
Angle PLC Announces Notice of Interim Results and Webcast
September 16, 2024
Angle PLC - Data Supporting FDA Approval Published in Journal
August 21, 2024
Angle PLC Announces Potential Utility in Precision Oncology
January 21, 2024
Angle PLC Announces Standard Form for Notification of Major Holdings
January 10, 2024
Angle PLC - Contract announcement with Eisai Inc.
January 01, 2024
Angle PLC Announces Parsortix Unlocks Opportunities for Drug Discovery
December 11, 2023
Angle PLC Announces Broker Announcement
December 11, 2023
ANGLE launches Portrait+ CTC kit at SABCS
December 05, 2023
Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies
November 09, 2023
Angle PLC Announces Trading and Business Update
November 09, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.